Is IRWD or JANX more undervalued in 2026?

CirclFi compares Ironwood Pharmaceuticals, Inc. (IRWD) and Janux Therapeutics, Inc. (JANX) using 13 institutional-grade valuation models. IRWD has a Quality of Company score of 7.6/10 while JANX scores 5.4/10.

Which is a better buy — IRWD or JANX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IRWD and JANX valuations compare?

IRWD at $3.57 and JANX at $14.59 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IRWD vs JANX Valuation Comparison 2026 — Intrinsic Value Analysis

IRWD

Pharmaceutical Preparations

Ironwood Pharmaceuticals, Inc.

Quality

7.6

out of 10

Value Trap

LOW

Price

$3.57

Last close

Models

12/13

Active

JANX

Pharmaceutical Preparations

Janux Therapeutics, Inc.

Quality

5.4

out of 10

Value Trap

SAFE

Price

$14.59

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	IRWD Fair Value	IRWD Upside	JANX Fair Value	JANX Upside
Bayesian DCF	Intrinsic	$15.29	+328.3%	$4.18	-71.3%
Earnings Power Value	Intrinsic	$5.71	+59.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.08	-97.8%	$9.03	-38.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IRWD vs JANX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IRWD vs JANX — Which Stock Is More Undervalued?

IRWD scores higher with a 7.6/10 quality rating vs JANX's 5.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Ironwood Pharmaceuticals, Inc. (IRWD) and Janux Therapeutics, Inc. (JANX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IRWD currently trades at $3.57 with a QOC of 7.6/10, while JANX trades at $14.59 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).